US · 2 sources covering this

FTC and seven states seek contempt ruling against Shkreli over pharma ban

Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and they are asking a judge to hold him in contempt. In a motion filed on Tuesday in US district court in New York City, the FTC and its state co-plainti…

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

2 L · 0 C · 0 R

How 2 sources are covering this

The GuardianLean L·2h ago
FTC and seven states seek contempt ruling against Shkreli over pharma ban
Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and they are asking a judge to hold him in contempt. In a motion filed on Tuesday in US district court in New York City, the FTC and its state co-plainti…
Read at The Guardian →
The GuardianLean L

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/7e6ad4b5b2985ea5345ac8071afbeeea925777e2"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="FTC and seven states seek contempt ruling against Shkreli over pharma ban"></iframe>

FTC and seven states seek contempt ruling against Shkreli over pharma ban

How 2 sources are covering this